Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | rhIL-15 |
| Trade Name | |
| Synonyms | recombinant human interleukin-15|rhIL15 |
| Drug Descriptions |
rHIL-15 is the recombinant human interleukin-15 which may stimulate and enhance anti-tumor immune response (PMID: 18582400, PMID: 31266741). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C1545 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Alemtuzumab + rhIL-15 | Alemtuzumab rhIL-15 | 0 | 1 |
| Avelumab + rhIL-15 | Avelumab rhIL-15 | 0 | 2 |
| Dinutuximab + Irinotecan + rhIL-15 + Temozolomide | Dinutuximab Irinotecan Temozolomide rhIL-15 | 0 | 1 |
| Ipilimumab + Nivolumab + rhIL-15 | Ipilimumab Nivolumab rhIL-15 | 0 | 1 |
| Ipilimumab + rhIL-15 | Ipilimumab rhIL-15 | 0 | 1 |
| Mogamulizumab + rhIL-15 | Mogamulizumab rhIL-15 | 0 | 1 |
| Nivolumab + rhIL-15 | Nivolumab rhIL-15 | 0 | 1 |
| Obinutuzumab + rhIL-15 | Obinutuzumab rhIL-15 | 0 | 1 |
| rhIL-15 | rhIL-15 | 0 | 0 |